Approved for JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis in adult patients, and for progressive pulmonary fibrosis in adult patients.. Nerandomilast is an inhibitor of phosphodiesterase 4 (PDE4) with preferential inhibition of the PDE4B isoform. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS…
Loading full data from Know Your Drugs Institute…